Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Reynolds Insider Profile
4 Followers
Steven Reynolds, Executive at Claritas Pharmaceuticals, holds 2.20M shares in Claritas Pharmaceuticals (Ticker: CLAZF). Most recently, Steven Reynolds Bought $72,500 shares of Claritas Pharmaceuticals on Jun 22, 2009 for an estimated value of 9.43K.
Steven Reynolds has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Steven Reynolds's holdings
Insider Roles
Executive
Roles that Steven Reynolds holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Steven Reynolds
Steven Reynolds's Trading History
List of latest transactions for each holding click on a transaction to see Steven Reynolds's performance on stock
You May Also Like
Steven Reynolds insider profile FAQ
What is the percentage of profitable transactions made by Steven Reynolds?
The percentage of profitable transactions made by Steven Reynolds is ―.
What is the average return per transaction made by Steven Reynolds?
The average return per transaction made by Steven Reynolds is ―.
What stocks does Steven Reynolds hold?
Steven Reynolds holds: CLAZF stocks.
What was Steven Reynolds’s latest transaction?
Steven Reynolds latest transaction was an Informative Buy of $9.43K.
What was Steven Reynolds's most profitable transaction?
Steven Reynolds’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Steven Reynolds's role in Claritas Pharmaceuticals?
Steven Reynolds's role in Claritas Pharmaceuticals is Executive.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.